University of Warwick researchers developed an organo-metal compound coded as FY26 to infiltrate cancer cells and activate cellular mitochondria to destroy cancer cells. To date, FY26 has been tested in ovarian cancer cells and has been deemed 50 times more effective and cheaper than other chemotherapy drugs. Can a newly discovered metallic compound vastly improve the treatment of ovarian cancer? https://www.spireresearch.com/newsroom/spirethoughts/precious-metal-destroys-cancer-cells/